Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)
India
· Delayed Price · Currency is INR 392.45
-6.50 (-1.63%)
Mar 9, 2026, 3:29 PM IST
NSE:INDRAMEDCO Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Revenue | 14,515 | 13,564 | 12,447 | 10,987 | 8,882 | 6,134 | Upgrade
|
| Revenue Growth (YoY) | 8.53% | 8.97% | 13.29% | 23.70% | 44.80% | -26.17% | Upgrade
|
| Cost of Revenue | 5,765 | 5,278 | 5,040 | 4,630 | 4,059 | 3,257 | Upgrade
|
| Gross Profit | 8,750 | 8,286 | 7,407 | 6,357 | 4,823 | 2,877 | Upgrade
|
| Selling, General & Admin | 876.5 | 876.5 | 1,066 | 894.6 | 552.1 | 284.5 | Upgrade
|
| Other Operating Expenses | 5,191 | 4,961 | 4,396 | 3,947 | 3,070 | 2,182 | Upgrade
|
| Operating Expenses | 6,499 | 6,281 | 5,863 | 5,234 | 3,972 | 2,800 | Upgrade
|
| Operating Income | 2,251 | 2,005 | 1,545 | 1,123 | 851.3 | 76.6 | Upgrade
|
| Interest Expense | -27.8 | -30.3 | -10.6 | -4.6 | -6.1 | - | Upgrade
|
| Interest & Investment Income | 226.5 | 226.5 | 168.9 | 100.3 | 31.2 | 6.8 | Upgrade
|
| Other Non Operating Income (Expenses) | 18.8 | -32.4 | -30 | -38.2 | -28 | -33.4 | Upgrade
|
| EBT Excluding Unusual Items | 2,468 | 2,168 | 1,673 | 1,181 | 848.4 | 50 | Upgrade
|
| Gain (Loss) on Sale of Assets | -5.2 | -5.2 | -11.7 | -8.7 | -57.7 | -7.1 | Upgrade
|
| Pretax Income | 2,463 | 2,163 | 1,661 | 1,172 | 790.7 | 42.9 | Upgrade
|
| Income Tax Expense | 633.5 | 553.3 | 421.5 | 310.3 | 204.5 | 19.6 | Upgrade
|
| Net Income | 1,829 | 1,610 | 1,240 | 861.5 | 586.2 | 23.3 | Upgrade
|
| Net Income to Common | 1,829 | 1,610 | 1,240 | 861.5 | 586.2 | 23.3 | Upgrade
|
| Net Income Growth | 21.02% | 29.87% | 43.89% | 46.96% | 2415.88% | -94.66% | Upgrade
|
| Shares Outstanding (Basic) | 92 | 92 | 92 | 92 | 92 | 92 | Upgrade
|
| Shares Outstanding (Diluted) | 92 | 92 | 92 | 92 | 92 | 92 | Upgrade
|
| EPS (Basic) | 19.95 | 17.56 | 13.52 | 9.40 | 6.39 | 0.25 | Upgrade
|
| EPS (Diluted) | 19.95 | 17.56 | 13.52 | 9.40 | 6.39 | 0.25 | Upgrade
|
| EPS Growth | 20.98% | 29.88% | 43.87% | 47.07% | 2456.00% | -94.75% | Upgrade
|
| Free Cash Flow | - | 1,204 | 1,308 | 998.9 | 648.2 | 58.5 | Upgrade
|
| Free Cash Flow Per Share | - | 13.14 | 14.26 | 10.90 | 7.07 | 0.64 | Upgrade
|
| Dividend Per Share | - | 4.500 | 4.500 | 3.000 | 2.500 | - | Upgrade
|
| Dividend Growth | - | - | 50.00% | 20.00% | - | - | Upgrade
|
| Gross Margin | 60.28% | 61.09% | 59.51% | 57.86% | 54.30% | 46.90% | Upgrade
|
| Operating Margin | 15.50% | 14.78% | 12.41% | 10.22% | 9.59% | 1.25% | Upgrade
|
| Profit Margin | 12.60% | 11.87% | 9.96% | 7.84% | 6.60% | 0.38% | Upgrade
|
| Free Cash Flow Margin | - | 8.88% | 10.51% | 9.09% | 7.30% | 0.95% | Upgrade
|
| EBITDA | 2,680 | 2,405 | 1,907 | 1,477 | 1,160 | 371 | Upgrade
|
| EBITDA Margin | 18.46% | 17.73% | 15.32% | 13.44% | 13.06% | 6.05% | Upgrade
|
| D&A For EBITDA | 429.13 | 400.7 | 362.8 | 354 | 308.3 | 294.4 | Upgrade
|
| EBIT | 2,251 | 2,005 | 1,545 | 1,123 | 851.3 | 76.6 | Upgrade
|
| EBIT Margin | 15.50% | 14.78% | 12.41% | 10.22% | 9.59% | 1.25% | Upgrade
|
| Effective Tax Rate | 25.72% | 25.58% | 25.37% | 26.48% | 25.86% | 45.69% | Upgrade
|
| Revenue as Reported | 14,792 | 13,790 | 12,616 | 11,087 | 8,913 | 6,141 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.